Sign in
4

Changes in Ownership

Bolt Biotherapeutics, Inc. Filed Acc 0000899243-22-007525

Options or other derivatives

  • Chief Business Officer acquired 190,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Yonehiro Grant · Chief Business Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-02-18 Grant or award : show line 1 in the form Stock Option (Right to Buy) +190,000 190,000 D
Loading xslF345X03/doc4.xml…